medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (2)

Knowledge about warning signs and symptoms of COVID-19 in the population of Lima, Peru

Raraz-Vidal JG, Allpas-Gomez HL, Arenas-Lupo MR, Raraz-Vidal YF, Raraz-Vidal OB, Gonzales-Rengifo G

Language: Spanish
References: 34
Page: 1-16
PDF size: 309.53 Kb.


ABSTRACT

Introduction: COVID-19 is a highly infectious disease which may cause great mortality among people with comorbidities. It is thus considered to be a global public health problem.
Objective: Evaluate the level of knowledge about warning signs and symptoms of COVID-19 in the population of Lima, Peru.
Methods: A cross-sectional descriptive study was conducted. In compliance with the selection criteria, a sample of 307 patients was obtained through a virtual survey applied in the city of Lima from 15 June to 8 July 2020. The tool was validated by expert judgment and Kr-20 (0.71). Bivariate analysis was based on the chi-square test, and the Kruskal-Wallis and Mann-Whitney U statistical tests were used for differences in knowledge means, in view of their non-parametric distribution (Kolmogorov-Smirnov: p < 0.05). A confidence interval of 95% and a value of p < 0.05 were considered to be statistically significant.
Results: Mean age of participants was 37.5 ± 13.5 years. Prevalence of poor knowledge was 48.2%. The warning sign most commonly identified by the population was dyspnea. Of the population surveyed, 55% knew of at least one warning sign. The symptoms most frequently recognized by the population were loss of taste, fever, headache and a sore throat. Women were better than men identifying warning signs (p < 0.05). People with an independent job and secondary education had difficulty identifying COVID-19 warning signs (p < 0.05).
Conclusion: Nearly half of the population studied had poor knowledge about the warning signs and symptoms of COVID-19. Dyspnea was the warning sign most commonly identified by the population.


REFERENCES

  1. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male. 2020;23(5):1-9.

  2. Luan R-S, Wang X, Sun X, Chen X-S, Zhou T, Liu Q-H, et al. Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51(2):131-8.

  3. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. International Journal of Surgery. 2020;78:185-93.

  4. Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020. [acceso: 28/07/2020]. Disponible en: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

  5. Munayco CV, Tariq A, Rothenberg R, Soto-Cabezas GG, Reyes MF, Valle A, et al. Early transmission dynamics of COVID-19 in a southern hemisphere setting: Lima-Peru: February 29th–March 30th, 2020. medRxiv. 2020, [acceso: 29/07/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273285/pdf/nihpp-2020.04.30.20077594.pdf

  6. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.

  7. Misra AK, Rai RK, Takeuchi Y. Modeling the control of infectious diseases: Effects of TV and social media advertisements. Math Biosci Eng. 2018;15(6):1315-43.

  8. Landis JR, Koch GG. The Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33(1):159-74.

  9. Chan EYY, Huang Z, Lo ESK, Hung KKC, Wong ELY, Wong SYS. Sociodemographic Predictors of Health Risk Perception, Attitude and Behavior Practices Associated with Health-Emergency Disaster Risk Management for Biological Hazards: The Case of COVID-19 Pandemic in Hong Kong, SAR China. Int J Environ Res Public Health. 2020;17(11):3869-87.

  10. Karasneh R, Al-Azzam S, Muflih S, Soudah O, Hawamdeh S, Khader Y. Media’s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. Res Social Adm Pharm. 2020;17(1). PMCID: PMC7179508

  11. Ayçaguer S, Carlos L. El papel de los medios masivos de información en materia de salud. Revista Cubana de Salud Pública. 2012;38:759-70.

  12. Feo Acevedo C, Feo Istúriz O. Impacto de los medios de comunicación en la salud pública. Saúde debate. 2013;37(96):84-95.

  13. Raraz-Vidal J, Raraz-Vidal O, Damaso-Mata B, Cáceres-Collque E, Allpas-Gómez HL. Factores relacionados a la metaplasia intestinal en un hospital público en Huánuco. Acta Médica Peruana. 2014;31(3):176-80.

  14. Dámaso-Mata BC, Carbajal-Álvarez C, Loza-Munarriz C, Raraz-Vidal O, Raraz-Vidal J. Factores relacionados a la mortalidad perinatal en un hospital público de Huánuco. Acta Médica Peruana. 2014;31(1):15-22.

  15. Allpas-Gómez HL, Raraz-Vidal J, Raraz-Vidal O. Factores asociados al bajo peso al nacer en un hospital de Huánuco. Acta Médica Peruana. 2014;31(2):79-83.

  16. Málaga G. Las enfermedades crónicas no transmisibles, un reto por enfrentar. Revista Peruana de Medicina Experimental y Salud Pública. 2014;31(1):6-8.

  17. OMS. Financiamiento de la salud en las Américas. 2014. [acceso: 24/07/2020]. Disponible en: https://www.paho.org/salud-en-las-americas-2017/?post_t_es=financiamiento-de-la-salud-universal

  18. Ministerio de Economía y Finanzas. MEF: Gobierno destinará 12 puntos del PBI para enfrentar covid-19 y reactivar economía. Perú; 2020. [acceso: 24/07/2020]. Disponible en: http://elperuano.pe/noticia-mef-gobierno-destinara-12-puntos-del-pbi-para-enfrentar-covid19-y-reactivar-economia-93665.aspx

  19. Vílchez JGS. La atención primaria de la salud. Revista Peruana de Medicina Experimental y Salud Pública. 2013 [acceso: 24/07/2020]; 30(2). Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/186

  20. Rios-González CM. Knowledge, attitudes and practices towards COVID-19 in Paraguayans during outbreaks: a quick online survey. 2020 [acceso: 23/07/2020]. Disponible en: https://preprints.scielo.org/index.php/scielo/preprint/view/149

  21. Tejeda JJG, Guach RAD, Abreu MRP, Velazquez OT, Tamayo AEI. Evaluación del nivel de conocimiento sobre COVID-19 durante la pesquisa en la población de un consultorio. 2020;59(277):925.

  22. Akalu Y, Ayelign B, Molla MD. Knowledge, Attitude and Practice Towards COVID-19 Among Chronic Disease Patients at Addis Zemen Hospital, Northwest Ethiopia. IDR. 2020;13:1949-60.

  23. Honarvar B, Lankarani KB, Kharmandar A, Shaygani F, Zahedroozgar M, Rahmanian Haghighi MR, et al. Knowledge, attitudes, risk perceptions, and practices of adults toward COVID-19: a population and field-based study from Iran. Int J Public Health. 2020. DOI: 10.1007/s00038-020-01406-2

  24. Al-Hanawi MK, Angawi K, Alshareef N, Qattan AMN, Helmy HZ, Abudawood Y, et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Front Public Health. 2020;8:217. DOI: 10.3389/fpubh.2020.00217.

  25. Geldsetzer P. Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey. Annals of Internal Medicine. 2020;173(2):157-60.

  26. Azlan AA, Hamzah MR, Sern TJ, Ayub SH, Mohamad E. Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia. PLoS ONE. 2020;15(5):e0233668.

  27. Zhong B-L, Luo W, Li H-M, Zhang Q-Q, Liu X-G, Li W-T, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745-52.

  28. Sari DK, Amelia R, Dharmajaya R, Sari LM, Fitri NK. Positive Correlation Between General Public Knowledge and Attitudes Regarding COVID-19 Outbreak 1 Month After First Cases Reported in Indonesia. J Community Health. 2020;24:1-8.

  29. Liu X, Yue X, Liu F, Wei L, Chu Y, Bao H, et al. Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study. PLOS ONE. 2020;15(6):e0235459.

  30. Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol. 2020;127:104371. 31. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. Published online. 2020. DOI: 10.1001/jama.2020.12839

  31. Ek S. Gender differences in health information behaviour: a Finnish population-based survey. Health Promot Int. 2015;30(3):736-45.

  32. Mulderij-Jansen V, Elsinga J, Gerstenbluth I, Duits A, Tami A, Bailey A. Understanding risk communication for prevention and control of vector-borne diseases: A mixed-method study in Curaçao. PLoS Negl Trop Dis. 2020;14(4):e0008136.

  33. Brunello G, Fort M, Schneeweis N, Winter-Ebmer R. The Causal Effect of Education on Health: What is the Role of Health Behaviors? Health Econ. 2016;25(3):314-36.

  34. Wolf MS, Serper M, Opsasnick L, O’Conor RM, Curtis L, Benavente JY, et al. Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey. Ann Intern Med. 2020;173(2):100-9.




2020     |     www.medigraphic.com